Evidence map›Paper›PMID 41708003›Full record

ArticleThe Journal of biological chemistry2026

Structural insights into specific recognition of the histone variant H2A.Z by the YL1 subunit of SRCAP chromatin-remodeling complex.

Wansen Tan, Yue Liu, Jingjun Hong

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wansen TanInstitute of Health Sciences and Technology (IHST), Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, China.
Yue LiuSchool of Life Science and Medical Engineering, Anhui University, Hefei, China.
Jingjun HongInstitute of Health Sciences and Technology (IHST), Institutes of Physical Sciences and Information Technology, Anhui University, Hefei, China; School of Life Science and Medical Engineering, Anhui University, Hefei, China. Electronic address: jjhong@ahu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SNF2-related CREB-binding protein activator protein complex regulates gene transcription through chromatin remodeling, where the subunit YL1 mediates the exchange of H2A-H2B dimers with H2A.Z-H2B in the nucleosome. Although structures of YL1 in complex with H2A.Z-H2B have been previously reported for both Drosophila and Homo sapiens, the complex structures of the two species exhibit significant differences, which have caused some confusion over how YL1 recruits H2A.Z-H2B. We determined the high-resolution (2.01 Å) crystal structure of the N-terminal region (8-73) of the human SNF2-related CREB-binding protein activator protein subunit YL1 in complex with H2B-H2A.Z; this domain is termed as YL1-Z. YL1-Z consists of an alpha helix and a longer loop, which bind to H2A.Z-H2B to form a complex. In the structure, residues Phe29, Tyr30, Tyr34, and Phe37 of the YL1-Z domain specifically recognize the hydrophobic residues, Gln87, Ile90, Ile100, and Ile104, of H2A.Z through hydrophobic interactions, forming a hydrophobic core. In addition, residues Asp55, Asp58, and Asp60 of YL1-Z form electrostatic interactions with Arg34 and Lys37 on H2A.Z, stabilizing the complex structure. The particular recognition has been validated in vitro by maltose-binding protein-pulldown and isothermal titration calorimetry experiments. Our data show that YL1 employs a conserved structural mechanism for recognizing the H2A.Z-H2B dimer.

Indexed as

Adenosine TriphosphatasesChromatin Assembly and DisassemblyHistonesAmino Acid SequenceAnimalsCrystallography, X-RayHumansModels, MolecularProtein BindingProtein SubunitsAdenosine TriphosphatasesHistonesProtein SubunitsSRCAP protein, humancrystal structureH2A.ZITCpull-downYL1

Identifiers

PMID41708003
PMCPMC12993189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.